79 results
Page 2 of 4
8-K
EX-1.1
df6di70dc09 zv
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
8-K
EX-99.1
u1evgw8b3ouru b0
13 Sep 22
POINT Biopharma Announces Proposed Public Offering of Common Stock
4:12pm
8-K
EX-99.1
oc9 g34sih5xd
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
8-K
EX-99.1
g7cxdfeuv3b 06nnct
6 Sep 22
POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
8:11am
S-3
EX-1.2
kz2p4sl
1 Jul 22
Shelf registration
4:13pm
424B3
EX-99.1
fae 59l8hcj7
16 May 22
Prospectus supplement
8:27am
8-K
EX-99.1
nbczgg
16 May 22
Other Events
8:20am
424B3
v9x2 6f11ar
31 Mar 22
Prospectus supplement
11:42am
POS AM
prqti
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
temd dzcn
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
EX-99.2
msv rypopva
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.2
b4t14rlzhrakl
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
EX-99.1
0p533sr0 ga
1 Dec 21
Prospectus supplement
8:25am
8-K
EX-99.1
1aag0pg2
1 Dec 21
Departure of Directors or Certain Officers
8:14am
424B3
EX-10.1
sv26ys
12 Nov 21
Prospectus supplement
8:41am
424B3
s58fl
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
we638
28 Sep 21
Entry into a Material Definitive Agreement
8:53am